marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Agios Pharmaceuticals Financial Ratios 2011-2024 | AGIO
Annual Financial Ratios Agios Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.2 | -6.1 | 1.2 | -9.1 | -7.6 | -8.6 | -11.9 | -8.0 | -13.4 | -72.9 | -11.1 | - | - |
P/S |
55.6 | 99.6 | - | 14.7 | 26.5 | 31.4 | 87.3 | 22.7 | 26.7 | 59.7 | 17.1 | - | - |
EPS |
-6.3 | -4.2 | 26.6 | -4.7 | -6.9 | -6.0 | -6.8 | -5.1 | -3.1 | -1.6 | -2.8 | -8.0 | -8.9 |
EV (Enterprise Value) |
1.53 B | 1.42 B | 1.93 B | 3.32 B | 3.29 B | 3.06 B | 3.89 B | 1.68 B | 1.58 B | 3.96 B | 435 M | 1.81 M | 13.7 M |
EBITDA per Share |
-6.92 | -6.95 | -6.11 | -4.73 | -6.97 | -6.19 | -6.75 | -4.99 | -3.08 | -1.57 | -2.43 | - | - |
EV/EBITDA |
-5.1 | -10.2 | -7.3 | -8.1 | -11.6 | -7.3 | -13.1 | -73.7 | -9.8 | - | - | ||
PEG |
-0.92 | -2.02 | 0.17 | -0.66 | 0.55 | -0.8 | 0.36 | 0.13 | 0.14 | -1.66 | 0.08 | - | - |
P/B |
1.8 | 1.3 | 1.5 | 7.5 | 4.9 | 4.3 | 10.0 | 4.4 | 4.6 | 9.2 | 3.3 | - | - |
P/CF |
-5.0 | -4.6 | -4.9 | -10.3 | -8.2 | -9.5 | -13.0 | 55.3 | -16.3 | -63.4 | -7.6 | - | - |
ROE % |
-43.41 | -21.06 | 124.21 | -81.94 | -64.24 | -50.33 | -83.80 | -55.35 | -34.11 | -12.61 | -29.97 | - | - |
ROA % |
-37.57 | -18.71 | 111.61 | -38.38 | -46.19 | -40.31 | -51.22 | -32.06 | -28.03 | -10.88 | -19.59 | - | - |
ROCE % |
-48.27 | -35.34 | -29.29 | -84.08 | -53.43 | -47.39 | -61.76 | -37.87 | -32.33 | -12.57 | -23.67 | - | - |
Current Ratio |
7.4 | 9.0 | 9.9 | 1.9 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | 4.6 | - | - |
DSO |
- | - | - | - | 47.4 | 40.4 | 32.6 | 43.4 | 71.6 | 70.7 | 6.8 | - | - |
DIO |
1746.3 | 909.5 | - | 477.0 | 2031.8 | 227.0 | - | - | - | - | - | - | - |
DPO |
1798.8 | 3782.4 | - | 3171.1 | 6068.4 | 4671.6 | - | - | - | - | - | - | - |
Operating Cycle |
1746.3 | 909.5 | - | 477.0 | 2079.2 | 267.4 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-52.5 | -2872.9 | - | -2694.2 | -3989.2 | -4404.2 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Agios Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
16.65 | -1.69 | -1.45 | - | -1.64 | -1.51 | -1.47 | - | -1.49 | -1.68 | -1.74 | -1.74 | -1.56 | -1.41 | 26.95 | -1.41 | -1.43 | -1.31 | -0.59 | -1.6 | -1.81 | -1.87 | -1.59 | -1.58 | -1.63 | -1.19 | -1.63 | -1.81 | -1.59 | -1.78 | -1.56 | -1.34 | -1.63 | -1.47 | -0.61 | -1.08 | -1.07 | -0.85 | -0.13 | -0.76 | 0.11 | -0.54 | -0.39 | -0.4 | -0.52 | -2.8 | -2.47 | -2.09 | -0.83 | -2.18 | -1.98 | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | -1.66 | -1.78 | -1.85 | - | -1.6 | -1.49 | -1.31 | -1.33 | -1.16 | -1.21 | -1.23 | -1.55 | -1.85 | -1.87 | -1.63 | -1.66 | -1.62 | -1.2 | -1.66 | -1.85 | -1.53 | -1.74 | -1.55 | -1.36 | -1.54 | -1.42 | -0.59 | -1.08 | -1.02 | -0.83 | -0.13 | -0.72 | 0.12 | -0.53 | -0.38 | -0.39 | -0.44 | -2.1 | -1.83 | -1.8 | -1.24 | -1.66 | - | - | - | - | - |
ROE % |
22.46 | -46.11 | -40.25 | -26.81 | -34.59 | -32.08 | -31.55 | -23.80 | -31.12 | -29.70 | -26.54 | 62.92 | 45.80 | 27.38 | 9.74 | -81.94 | -73.48 | -65.28 | -59.78 | -64.24 | -61.61 | -58.80 | -51.65 | -50.33 | -60.49 | -67.26 | -79.39 | -83.80 | -66.76 | -63.74 | -57.22 | -46.06 | -51.37 | -45.51 | -39.15 | -34.11 | -28.63 | -16.09 | -11.16 | -12.61 | -15.74 | -25.12 | -27.36 | -29.97 | -13.18 | 1.77 | 15.98 | 21.48 | 14.10 | 7.65 | - | - | - | - | - |
ROA % |
21.81 | -40.16 | -35.45 | -23.83 | -30.75 | -28.61 | -27.98 | -21.12 | -27.70 | -19.43 | -24.03 | 58.38 | 53.51 | 47.67 | 41.66 | -38.38 | -38.42 | -38.74 | -40.46 | -46.19 | -45.40 | -44.50 | -40.18 | -40.31 | -43.98 | -45.51 | -51.03 | -51.22 | -40.59 | -38.19 | -33.70 | -26.68 | -32.60 | -32.04 | -30.59 | -28.03 | -23.78 | -13.44 | -9.57 | -10.88 | -11.61 | -17.92 | -18.48 | -19.59 | -17.31 | -15.14 | -14.88 | -11.29 | -7.41 | -4.02 | - | - | - | - | - |
ROCE % |
-46.09 | -51.15 | -44.85 | -29.84 | -38.51 | -35.81 | -34.78 | -25.74 | -32.27 | -30.13 | -26.75 | -15.81 | -38.94 | -52.50 | -68.05 | -85.86 | -79.26 | -76.19 | -73.13 | -66.56 | -64.04 | -61.43 | -54.27 | -52.72 | -62.71 | -69.33 | -81.25 | -85.43 | -77.44 | -74.11 | -67.32 | -56.05 | -51.89 | -45.91 | -39.47 | -34.39 | -28.84 | -16.36 | -11.37 | -12.76 | -15.77 | -24.94 | -27.11 | -29.57 | -11.24 | 4.27 | 19.26 | 24.62 | 15.60 | 8.50 | - | - | - | - | - |
Current Ratio |
10.8 | 6.9 | 8.0 | 7.4 | 8.4 | 9.0 | 10.0 | 9.0 | 9.1 | - | 10.4 | 9.9 | 10.5 | 12.3 | 13.0 | 1.9 | 1.9 | 1.9 | 1.9 | 3.6 | 3.6 | 3.6 | 3.6 | 5.0 | 5.0 | 5.0 | 5.0 | 2.6 | 2.6 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | 240.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.9 | 4.8 | 6.6 | 17.0 | 29.9 | 13.8 | 34.8 | 44.8 | 9.9 | 49.5 | 56.2 | 23.3 | 7.6 | 14.6 | 6.3 | 25.3 | 12.7 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
2934.8 | 1434.6 | 3066.8 | - | 2374.6 | 1113.7 | 1636.1 | - | 456.8 | 260.6 | 334.4 | - | - | - | - | - | 1616.3 | 1420.0 | 1464.5 | - | 1702.2 | 2207.8 | 1120.1 | - | 114.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1583.7 | 646.7 | 1523.4 | - | 1794.5 | 835.4 | 2246.5 | - | 919.1 | 1211.5 | 3802.2 | - | - | - | - | - | 2535.0 | 2396.0 | 3391.5 | - | 5084.0 | 6594.1 | 5433.5 | - | 2347.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
2934.8 | 1434.6 | 3066.8 | - | 2374.6 | 1113.7 | 1636.1 | - | 456.8 | 260.6 | 574.5 | - | - | - | - | - | 1616.3 | 1420.0 | 1464.5 | - | 1702.2 | 2207.8 | 1120.1 | - | 114.1 | - | 0.9 | 4.8 | 6.6 | 17.0 | 29.9 | 13.8 | 34.8 | 44.8 | 9.9 | 49.5 | 56.2 | 23.3 | 7.6 | 14.6 | 6.3 | 25.3 | 12.7 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
1351.2 | 787.9 | 1543.5 | - | 580.1 | 278.2 | -610.4 | - | -462.3 | -950.9 | -3227.7 | - | - | - | - | - | -918.6 | -976.0 | -1927.0 | - | -3381.8 | -4386.3 | -4313.3 | - | -2233.4 | - | 0.9 | 4.8 | 6.6 | 17.0 | 29.9 | 13.8 | 34.8 | 44.8 | 9.9 | 49.5 | 56.2 | 23.3 | 7.6 | 14.6 | 6.3 | 25.3 | 12.7 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency